Council of Scientific and Industrial Research

Actavis Group Ptc Ehf

Nilesh Sudhir Patil

Vasant Ramchandra Choudhary

Nitin Sharadchandra Pradhan

Balu Shivaji Uphade

Suman Kumar Jana

Jon Valgeirsson

Mayur Devjibhai Khunt

Prabhas Jana

Haushabhau Shivaji Pagire

Praveen Kumar Neela

Described is a highly stable amorphous form of imatinib mesylate having a water content of less than 0.5 percent by weight, based on the total weight of the amorphous imatinib mesylate, (anhydrous amorphous imatinib mesylate), a process for preparation thereof, and pharmaceutical compositions.

Anhydrous amorphous imatinib mesylate

The present invention relates to a process for the liquid phase epoxidation of a normally liquid olefinic compound to corresponding organic epoxide compound using aqueous or anhydrous organic hydroperoxide as an oxidizing agent in the presence of a supported nano-gold catalysts at the effective organic hydroperoxide/olefinic compound mole ratio, catalyst/olefinic compound weight ratio and temperature to yield the epoxide.

Process for epoxidation of a liquid olefinic organic compound using a supported nano-gold catalyst

Process for the acylation of aromatic compounds using a reusable solid catalyst comprising indium halide

Growing community of inventors

Maharashtra, India

Nilesh Sudhir Patil